Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company ...
The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...
Combining psychotherapy with low-dose ketamine is a relatively new approach to treating severe depression and post-traumatic ...
Ketamine clinics have been growing in popularity as an alternative depression treatment, but after the death of celebrity ...
The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically ...
Ministers said there were also growing concerns about THC vapes laced with ‘spice’, as well as synthetic opioids being sold ...
University life's celebrations can take a dangerous turn with the rise of ketamine use among young adults. This dissociative ...
Family members of those who have died from taking the ‘horrific’ Class B are among those calling for it to be reclassified ...
When used for mental health treatment, a dose of ketamine — typically half a milligram per kilogram of body weight, less than ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback